Our protocol uses an estrogen receptor 'blocker' that is actually studied to reduce Gynecomastia (development of breast tissue) at higher dosages, so this is unlikely to be an issue with our protocol.
Are there any affects of Gynecomastia?
Written by Mickler
Updated over 2 years ago